Selectively-infective phage (SIP) is a novel methodology for the in vivo selection of interacting protein-ligand pairs. It consists of two components, (1) a phage particle made non-infective by replacing its N-terminal domains of geneIII protein (gIIIp) with a ligand-binding protein, and (2) an``adapter'' molecule in which the ligand is linked to those N-terminal domains of gIIIp which are missing from the phage particle. Infectivity is restored when the displayed protein binds to the ligand and thereby attaches the missing N-terminal domains of gIIIp to the phage particle. Phage propagation is thus strictly dependent on the protein-ligand interaction. We have shown that the insertion of b-lactamase into different positions of gIIIp, mimicking the insertion of a protein-ligand pair, led to highly infective phage particles. Any phages lacking the ®rst N-terminal domain were not infective at all. In contrast, those lacking only the second N-terminal domain showed low infectivity irrespective of the presence or absence of the F-pilus on the recipient cell, which could be enhanced by addition of calcium. An anti-¯uor-escein scFv antibody and its antigen¯uorescein were examined as a proteinligand model system for SIP experiments. Adapter molecules, synthesized by chemical coupling of¯uorescein to the puri®ed N-terminal domains, were mixed with non-infective anti-¯uorescein scFv-displaying phages. Infection events were strictly dependent on¯uorescein being coupled to the N-terminal domains and showed a strong dependence on the adapter concentration. Up to 10 6 antigen-speci®c events could be obtained from 10 10 input phages, compared to only one antigen-independent event. Since no separation of binders and non-binders is necessary, SIP is promising as a rapid procedure to select for high af®nity interactions.
Introduction
The identi®cation of protein-ligand interactions is one of the most important challenges in biological sciences, both for identifying new interaction partners in regulatory networks (Phizicky & Fields, 1995) and for ®nding and improving pharmaceutical lead structures (O'Neil & Hoess, 1995) . Numerous methods for screening large peptidic libraries for protein-ligand interactions by physically coupling the protein or peptide to its gene have been described (reviewed by Phizicky & Fields, 1995) . In phage display (Smith, 1985) , one of the binding partners is fused to a phage coat protein of a ®la-mentous phage (Figure 1 a and b) , and the selection procedure involves the enrichment of phages which bind to a given immobilized target molecule (Clackson & Wells, 1994; Winter et al., 1994) . In phage display the phage particle remains infective because of the presence of wt geneIII protein (gIIIp) (Figure 1b) . Consequently, the DNA of both non-speci®cally and speci®cally bound phages enters the bacterial cell by infection, after they have been eluted from the ligand surface. The main challenge of phage display is thus to minimize non-speci®c adsorption of the phages in the binding procedure (Adey et al., 1995) and to enrich phage which display high-af®nity molecules over highly abundant, low-af®nity binders (Hawkins et al., 1992) .
Here, we investigate the mechanism of selectively-infective phage (SIP) (Krebber et al., 1993 (Krebber et al., , 1995 Duenas & Borrebaeck, 1994; Gramatikoff et al., 1994) . In SIP, in contrast to phage display, the desired protein-ligand interaction, in this study exempli®ed by an antibody-antigen interaction, is itself directly responsible for restoring infectivity in an otherwise non-infective display phage ( Figure 1c ). This is achieved by exploiting the modular structure of gIIIp of wt ®lamentous phage ( Figure 2a ) (Armstrong et al., 1981; Stengele et al., 1990) . The gIIIp consists of three domains of 68 (N1), 131 (N2) and 150 (CT) amino acids, connected by glycinerich linkers of 18 (G1) and 39 (G2) amino acids, respectively ( Figure 2a) . The ®rst N-terminal domain, N1, is thought to be involved in penetration of the bacterial membrane, the second N-terminal domain, N2, in binding of the bacterial F-pilus (Stengele et al., 1990; Jakes et al., 1988) . The C-terminal domain (CT) plays a role in phage morphogenesis and caps one end of the phage particle (Nelson et al., 1981; Crissman & Smith, 1984) .
After synthesis in the cytoplasm the preprotein of gIIIp is transported through the inner membrane, and the signal sequence is then cleaved off (Ito et al. 1980) , while processed gIIIp is inserted in the inner membrane of Escherichia coli via a short C-terminal peptide (Davis et al., 1985; Endemann & Model, 1995) . In the inner membrane it oligomerizes and associates with gVIp, to be taken up by the budding phage (Gailus et al., 1994a; . This complex of three to ®ve copies of gIIIp and gVIp forms the end of the phage particle (Davis et al., 1985) which leaves the host cell last (Lopez & Webster, 1983) . In the phage particles, the C-terminal domain (CT) is part of the coat structure and thereby anchors the N-terminal domains of gIIIp to the phage particle (Davis et al., 1985) . The glycine-rich linkers G1 and G2 have been shown to enhance the infectivity of the phage (Rampf, 1993; Endemann et al., 1993) , probably by Figure 1 . Concept of selectively-infective phages (SIP) in comparison to wt phages and phages used for phage display. a, wt phage. The gIIIp is needed for infectivity, i.e. entry of the phage into bacteria (see the text and Figure 2 ). b, Classical phage display particle. By using phagemid/helper phage systems, both wt gIIIp and the fusion of the ligand binding protein to the C-terminal domain of gIIIp are present in the same phage particle. The phage particle can both bind a ligand and remain infective. c, SIP: the wt gene in the phage genome is replaced by the ligand binding protein, fused to the C-terminal portion of gIIIp. Therefore, the fusion protein is present in all copies, which renders the phage noninfective by the complete absence of the N-terminal domains of gIIIp. The missing N-terminal domains of gIIIp are supplied to the phage particle by thè`a dapter'', which contains the covalently linked ligand. Only by the ligand binding to the displayed protein, the phage becomes infective. Figure 2 . a, The geneIII adsorption protein of F-speci®c ®lamentous phage, with the three-domain structure indicated. The nomenclature is as used throughout the text, with the ®rst N-terminal domain labelled N1, the second N-terminal domain N2 and the C-terminal domain CT, interspersed by two glycine-rich linkers G1 and G2. b, The adapter molecule contains the N-terminal domains (in this case N1 and N2) and links them to a ligand (in this case antigen), while the C-terminal domain is anchored in the phage coat and thereby attaches the displayed scFv to the phage particle. conferring¯exibility in connecting the three domains and adjusting the required distance in the 3D-structure.
The basis of SIP involves the separation of the N-terminal domains required for infection (N1 or N1-N2) from the anchoring C-terminal domain (Figure 2b ). In SIP the gene for a peptide or a protein (e.g. an anti-¯uorescein scFv) is used to replace the N1 or N1-N2 encoding parts by genetic fusion to the C-terminal part of geneIII, leading to a phage particle which is non-infective (Nelson et al., 1981; Crissman & Smith, 1984) and displays the encoded protein or peptide at one end of the phage particle (Smith, 1985) . The missing N-terminal domains are supplied within adapter molecules, which consist of the ligand covalently bound to these N-terminal domains. The ligand can be a protein, a peptide or a small organic compound (e.g. uorescein) . By adding the adapter molecule to the non-infective protein-displaying phage particles, protein-ligand complexes can form on the phage, if the displayed protein is able to bind to the ligand. The N-terminal domains of gIIIp become again connected to the phage particle and thereby the phage becomes infective. Thus, a rapid one-step method to select protein-ligand interactions results. Since SIP works without the involvement of solid phase interactions, the selection for high af®nity binders seems to be feasible (Duenas et al., 1996) .
In this study we investigated the in¯uence of different parameters on the process of selectivelyinfective phage. The ef®ciency of SIP is potentially in¯uenced by a number of parameters: the site where the protein-ligand will be inserted within gIIIp, the strength of the protein-ligand interaction, the folding yield of each binding partner and their resistance to proteolytic digestion. Furthermore, we wanted to test whether the N-terminal fragments of gIIIp themselves might have stimulatory or inhibitory effects on the infectivity of non-infective protein-displaying phage, independent of the presence of antigen in the adapter molecule.
In order to discriminate between these many factors, we ®rst constructed phage vectors which led to phage particles with b-lactamase inserted within gIIIp (Soumillion et al., 1994) at various locations. By spatially separating the N-terminal and C-terminal parts of gIIIp while retaining the covalent linkage between them, an in®nite binding constant between the protein-ligand pair is mimicked, and the theoretical limit of infectivity of the corresponding SIP complex can be deduced. In addition, the infectivity of phage particles displaying b-lactamase but lacking various domains of gIIIp was investigated, using both F-pilus expressing and F-pilus lacking recipient cells.
We then constructed two different non-infective anti-¯uorescein scFv-displaying phage particles and prepared adapter molecules from different puri®ed N-terminal fragments of gIIIp and coupled them to a¯uorescein derivative. Both components were then combined in quantitative selectively-infective phage experiments and the infectivity of the different phage-adapter complexes and their dependence on the adapter concentration was measured.
Results
Infectivity of b b b-lactamase gIII-fusions and the influence of Ca 2
In a ®rst set of experiments, we created a number of phages in which b-lactamase was inserted between the domains of gIIIp, or in which domains of gIIIp have been replaced by b-lactamase. The enzyme b-lactamase (Bla) was chosen since it acts in the periplasm. Since gIIIp is anchored to the periplasmic face of the inner membrane before it is inserted into the phage coat, its N-terminal domains are in effect in the periplasmic compartment, as is b-lactamase when fused to gIIIp. Indeed, this enzyme can be directly selected for (Siemers et al., 1996) , even when fused to gIIIp, by addition of ampicillin to the growth media. Thereby mutants which would recreate the wild-type gIII by deleting the Bla gene cannot skew the results. From the infectivity of those Bla-gIIIp fusions we can deduce the function of the various domains of gIIIp, thereby con®rming and extending previous deletion experiments (Stengele et al., 1990) . Most importantly, by using those Bla-gIIIp fusions, we also expected to gain new information about the tolerance of gIIIp to domain spacing and thus about the synergistic action of the three gIIIp domains during the infection process.
The different phage vectors (Figure 3c ), were constructed starting from fCKC, a cam R derivative of the fd phage (Krebber et al., 1995) . The fCKC vector contains unique restriction sites in gIII (Figure 3a ) which allowed the shuf¯ing of domains and b-lactamase (Figure 3b ). In all constructs ( Figure 3c ) the Bla-gIIIp fusion proteins were transported to the periplasm by signal sequences of either PelB, OmpA or gIIIp. The same fd cam R phage vectors were also used to construct the noninfective scFv displaying phages described below (Figure 3e ).
Every insertion of Bla into gIIIp retained high phage infectivity for F recipient cells (Table 1 ). Insertions behind the second N-terminal domain (N1-N2-Bla-CT, N1-N2Bla-CT in Figure 3c ) still allowed the production of plaques, but they were smaller than those resulting from fCKC (N1-N2-CT; Figure 3a and c), which served as``wt'' control. This was re¯ected in a 100-fold lower infectivity of those Bla-insertions (Table 1 ). The insertion of Bla between the two N-terminal domains (N1-Bla-N2-CT, Figure 3c ) led to a 10 4 -fold lower infectivity (Table 1) , which was insuf®cient for producing plaques. This lower infectivity suggests either a direct binding interaction of N1 and N2 being disturbed by the insertion, or a functional but structurally independent cooperation of the two domains requiring a given distance.
Bla-gIIIp fusion constructs lacking the ®rst N-terminal domain (Bla-CT, Bla-N2-CT, N2Bla-CT) showed a complete loss of infectivity in all cases (Table 1 ). In contrast, for the construct only lacking the second N-terminal domain (N1-Bla-CT in Figure 3c ), some low infectivity could still be detected, and it could be increased by three to four orders of magnitude on addition of Ca 2 (Table 1) . For none of the other constructs could the infection of F -cells be enhanced by 50 mM Ca 2 (Table 1) .
When F À cells, cells which do not possess an Fpilus on their surface, were tested in the absence of Ca 2 , all Bla-gIIIp fusions showed very low or no infectivity at all (Table 1) , but upon addition of 50 mM Ca 2 , enhancements of two to four orders of magnitude were observed once the N1 domain was present (Table 1 ). In the presence of 50 mM Ca 2 , the N1-Bla-CT construct (Figure 3c ) showed even the same infectivity of 10 5 cfu/ml in F and F À recipient cells. This indicates that no infection at all occurs in the absence of N1 under any conditions, and that in the presence of only N1 and Ca 2 a F-pilus-independent infection occurs, since the results using F or F À cells as recipients are the same. Whenever N2 is present in addition to N1, the F-pilus-dependent infection is at least four orders of magnitude more ef®cient than F-pilus-independent, Ca 2 -mediated infection. Only the region¯anked by gene VIII and gene VI, which is different from fd phage, is depicted. wt fd phage has been modi®ed to contain a chloramphenicol resistance (cam R ) cassette in front of the central terminator, but keeping the original gene III promoter by a partial duplication, and introducing the indicated unique restriction sites within gene III (Krebber et al., 1995) . All parts of gene III are shaded in gray, and domains are shown as thick boxes and the glycine-rich linkers as thin boxes. b, Cassettes for constructing the Bla-fusion phages. The signal sequences used are indicated. Cassettes with the restriction sites indicated were constructed by PCR. The amino acid numbering below the boxes corresponds to the numbering of the proteins or domains without the respective signal peptide. c, Fusion proteins between Bla and various parts of gIII as present in fCKC derived vectors. The names of the corresponding phage are shown on the right; note that a hyphen indicates the presence of a glycine-rich linker. d, The gIIIp domains N1, N2 and N1-N2 were independently expressed without signal sequence and puri®ed. The amino acids from processed gIIIp are indicated. A hexahistidine puri®cation tail is engineered to the C terminus as indicated, which also contains a single cysteine, to which ligands can be chemically attached. e, Antibody scFv display phages. In the ''short'' phage (scFv-CT), the scFv is fused directly in front of the C-terminal domain CT, in the ''medium'' phage (scFv-N2-CT) it is fused in front of N2.
Inhibitory effects of gIIIp domains
For the design of SIP experiments it was important to know which concentrations of adapter molecules will show inhibitory effects on the infectivity of SIP complexes (Armstrong et al., 1981) . Furthermore, it had to be demonstrated that the N-terminal domains from which the adapters are made, were functional. Therefore, the N-terminal domains N1, N2, and N1-N2 ( Figure 3d ) were separately expressed and puri®ed.
To characterize the N1, N2, and N1-N2 preparations, each was used to inhibit the infection of F -recipient cells by N1-N2Bla-CT phage (Figure 3c ). N1 showed a half inhibitory concentration at 5 Â 10 À7 M, N2 at 2 Â 10 À8 M and N1-N2 even at 7 Â 10 À9 M (Figure 4 ). These results for N1-N2 and N1 did not change when¯uorescein was coupled to them (N1-N2-Flu, N1-Flu; data not shown). Interestingly, all N-terminal gIIIp fragments enhanced the infectivity of phage slightly (by a factor of 2) at a concentration just before the onset of inhibition (Figure 4) . We have currently no explanation of this phenomenon. The comparison of inhibitory properties (Figure 4) shows that N1 and N2 functionally interact, as the combination of both (N1-N2) inhibits at the lowest concentration. The difference in inhibition by N1 and N2 would be consistent with them acting at different sites, as suggested from the Bla-gIIIp fusion phage (Table 1) .
Since the adapter molecules N1-Flu and N1-N2-Flu, which were derived from the same N1 and N1-N2 preparations, were able to enhance infectivity of non-infective scFv-display phage (see below), the functionality of the N1 and N1-N2 preparations used in Figure 4 was demonstrated.
Specificity and quantification of infection in SIP experiments
Since the Bla-gIIIp fusion phages indicated the possibility of``interrupting'' the gIIIp structure either between N1 and N2 or between N2 and CT, and since the inhibitory effect of the N-terminal fragments of gIIIp, N1 and N1-N2 was found to be very different (Figure 4) , we decided to investigate all possibilities of combining adapter molecules and non-infective protein-displaying phage particles to create a selectively-infective phage complex ( Figure 5 ).
Two different scFv-display phages were produced: in the scFlu-``short'' phage the anti-¯uor-escein scFv FITC-E2 (Vaughan et al., 1996) was The phages containing the different Bla-fusions, with the dash (-) representing a Gly-rich linker, were used to infect the isogenic pair of JM83 (F À ) and JM83-F . 2YTG with and without addition of 50 mM Ca 2 was used for growth of the recipient bacteria. The number of phage particles produced by the host cells (E. coli XL1-Blue) was within less than one order of magnitude for all constructs. This was estimated by coating phage dilutions on an ELISA plate with subsequent detection of the phages with an anti-M13 horseradish peroxidase conjugate (Krebber et al., 1995) . The constructs used are shown in Figure 3 . fused in front of the second glycine-rich linker, so both N-terminal domains of gIIIp are missing in the phage particles (scFlu-CT, Figure 3e ). The scFlu-``medium'' phage contains N2 and thus places the scFv in front of the ®rst glycine-rich linker (scFlu-N2-CT; Figure 3e ). Both phage particles depicted in Figure 4 have in common that they do not contain the N1 domain (cf Bla-CT, Bla-N2-CT; Table 1 ) and indeed, the background infectivity of those scFlu-phage particles was very low (one to ten cfu per 10 10 input phages; data not shown). Two different antigen¯uorescein containing adapter molecules were synthesized by chemical coupling of a¯uorescein derivative to N1-N2 and N1 ( Figure 9 ) using a free thiol function genetically engineered in front of the C-terminal His-tag (Figure 3d ).
Both scFlu-short and scFlu-medium phages were tested for their regain of infectivity by addition of N1-Flu or N1-N2-Flu adapter protein ( Figure 5 ). N1-N2-Flu with scFlu-short phage (Figure 5b ) and N1-Flu with scFlu-medium phage (Figure 5c ) recreate the wt domain arrangement, albeit interrupted at a different point. In the combination of N1-Flu with scFlu-short phage the domain N2 is completely absent (Figure 5a ). In the combination N1-N2-Flu with scFlu-medium phage the N2 domain occurs twice, once in the adapter and once in the phage (Figure 5d ).
In the absence of chemically coupled¯uorescein, neither N1 nor N1-N2 was able to confer any signi®cant infectivity upon the anti-Flu scFv-short or medium phage (Table 2 , Figures 6 and 7) . This shows that the infection is completely dependent on the antibody-antigen interaction. The isolated, puri®ed N1, N2 and N1-N2 domains do not have the property of allowing``non-speci®c entry'' of a phage. Thus, we can conclude that the N1 or the N1-N2 domains need to be physically attached to the phage particle, in this case by the non-covalent binding interaction.
In a more quantitative comparison, differences between the effects of N1-Flu and N1-N2-Flu became apparent. Infectivity of scFlu-medium phage (scFv-N2-CT) increased as a function of N1-Flu concentration up to the highest concentration tested (10 À5 M), at which point it began to level off, yielding 1.2 Â 10 6 colonies from 10 10 input phages ( Figure 6 ). In contrast, N1-N2-Flu showed an optimum concentration for enhancement of infectivity at 3 Â 10 À8 M irrespective of using scFlu-short (scFv-CT) (Figure 7 ) or medium phage (scFv-N2-CT; data not shown), in both cases yielding 5 Â 10 4 colonies from 10 10 input phages. The infection of bacteria by the SIP complex formed in the presence of 2 Â 10 À8 M N1-N2-Flu and 10 9 scFlu-short phages (scFv-CT) could be inhibited by addition of free¯uorescein (Figure 8) , demonstrating that the infectivity is indeed due to the antibody-antigen interaction. The two different non-infective scFlu phages were incubated ON with the different N-terminal domains of gIIIp crosslinked or not crosslinked to the antigen. The cells were grown in 2YTG without addition of Mg 2 . The cells were used directly or they had 50 mM Ca 2 or 50 mM Mg 2 added immediately before use. The different types of interactions investigated here are shown schematically in Figure 5 . However, this Table also includes the controls without fused antigen (N1 and N1-N2).
Domains required for SIP and influence of metal ions
The low infectivity of the combination scFlushort phage and N1-Flu with F cells (Table 2 ) could be enhanced 30-fold in the presence of 50 mM Ca 2 , similar to the effects observed with the N1-Bla-CT fusion (Table 1) . Thus, SIP complexes are infective in the absence of N2, but then require Ca 2 . In contrast, whenever N2 was present in the SIP experiment (N1-Flu with scFlu-medium phage, or N1-N2-Flu with scFlu-short or scFlu-medium phage), Ca 2 had no stimulatory effect, and was even seen to inhibit infectivity slightly ( Table 2 ). The addition of Mg 2 to the cells shortly before adding N2-containing SIP-complexes enhanced the speci®c infectivity by four-to sixfold (Table 2) , and the effect of adding Mg 2 during growth of the bacteria was slightly stronger still (data not shown). These results suggest the existence of two pathways of infection, one using N2 for interaction with the pili and N1 for entry into the cell, and the other using only N1 in the presence of Ca 2 . As a consequence, the different combinations of adapters and scFv-displaying phage have different dependencies on the concentration of the soluble domains (Figures 6 and 7 , Table 2), and this knowledge allows us now to choose between them and to``tailor'' selection experiments.
Discussion
The principle of selectively-infective phage makes use of the modular structure of the infection mediating protein gIIIp of ®lamentous phage. In SIP infectivity of an otherwise non-infective phage particle is restored upon occurrence of a proteinligand interaction, which brings together the three domains of gIIIp (Figures 2 and 5 ). For the understanding of the function of the various components of the system, which is the prerequisite for the further development of SIP as a highly ef®cient selection tool, we had to identify the consequence of interrupting gIIIp at various points. Furthermore, the roles of the individual gIIIp domains in the infection process had to be clari®ed.
From b-lactamase insertion experiments, we found that increasing the spacing between gIIIp domains and the presence of a bulky protein did not destroy the infection process. However, as different positions of insertion led to different reductions of the infection ef®ciency, we must conclude that the three domains are not completely independent in their function. The ability of gIIIp Selectively-infective Phage to tolerate such big inserts in its structure without losing its function will have implications for standard phage display. For example, protein libraries may be inserted within gIIIp at the indicated sites, instead of at the N terminus. This will be advantageous for identifying robust and proteolysis resistant proteins, since only those phages would remain highly infective, from which N1 is not cleaved off.
The N1 domain of gIIIp was found, both from Bla-gIIIp fusion phages and SIP experiments, to be essential for the entry of the phage DNA into the cell under all conditions, consistent with previous reports (Armstrong et al., 1981; Stengele et al., 1990) . However, exogenously added N1 domain protein itself does not promote entry of unlinked non-infective phage into the cell; instead, N1 must be physically linked to the phage particle, either directly via genetic fusion, or via the non-covalent antibody-antigen interaction of SIP.
In contrast, if only the second N-terminal domain N2 is missing in the phage particle, a residual infectivity can be observed, but the ability to infect F recipient cells was much lower than in the presence of N2. This low N2-independent infectivity could be increased by one to four orders of magnitude by the addition of Ca 2 (Table 1) , consistent with previous results for wt phage (Russel et al., 1988) . In the absence of N2 in Bla-gIIIp phage, Ca 2 increases infectivity, independent of the presence of an F-pilus (Table 1) . These results demonstrate that the N2 domain is not necessary for the infection process itself. Instead, N2 confers speci®city towards F cells with a concomitant increase in infectivity, which is most simply explained by the N2 domain directly docking to the F-pilus (Armstrong et al., 1981) . Interestingly, the enhancement of infectivity towards F À cells by Ca 2 is lower by about one to two orders of magnitude if N2 is present (compare N1-Bla-CT with N1-Bla-N2-CT in Table 1 ). In SIP experiments Ca 2 even acts as an inhibitor (by a factor of 6 to 50) in the presence of N2 (Table 2) .
This suggests that there are two pathways of infection (F-pilus independent, strongly stimulated by Ca 2 and F-pilus dependent, requiring N2) which partially interfere with each other. Both pathways have an absolute requirement for N1, but the pathway mediated by N2 and the F-pilus is much more ef®cient. Thus, it is indeed possible to carry out SIP experiments in the absence of N2 (Table 2) (Duenas & Borrebaeck, 1994; Duenas et al., 1996) , but it appears to be necessary to use Ca 2 treated cells to overcome the loss of N2 (data not shown). We cannot distinguish whether Ca 2 has merely a direct effect on the cell envelope or may indirectly in¯uence uptake via the TolQRA system (Sun & Webster, 1987; Webster, 1991; Braun & Herrmann, 1993) . Consistent with these ideas of N2 function, the N-pilus speci®c phage IKe has no homologue of N2 (Peeters et al., 1985) , but does have domains homologous to N1 and CT of fd. Instead of N2, a different receptor domain is inserted in front of N1 of IKe (Endemann et al., 1992) . Further interactions between the domains of gIIIp are suggested by the failure of functional domain interchange between fd and IKe (Endemann et al., 1993) . One possible explanation for the results described is that a common precursor, possessing only N1 and using the above-mentioned pilusindependent pathway, diverged into fd and IKe, each using a different pilus type for enhanced infectivity.
The inhibition experiments with different puri®ed N-terminal gIIIp domains showed that N1 was less ef®cient at inhibiting infection than N2 or N1-N2 (Figure 4 ). This suggests that N1 interacts with its partner with a lower binding constant than N2 and probably at different sites: N1 may directly interact with the E. coli TolQRA-system (Sun & Webster, 1986; Russel et al., 1988; Webster, 1991) at micromolar concentrations. The Tol-system is known to be used both by several colicins and phages as an uptake mechanism, probably by transducing energy-dependent conformational changes (Braun & Herrmann, 1993; Lazdunski et al., 1995) . In contrast, the much stronger inhibitory effect of N2 suggests that it binds at the tip of the F-pilus with higher functional af®nity than N1 does at the E. coli envelope (Gray et al., 1981) (Figure 4) .
In SIP experiments, the stronger inhibitory effects of N2 and N1-N2 than of N1 are also re¯ected in the different adapter concentration optima when using N1-Flu (Figure 6 ) or N1-N2-Flu (Figure 7) . To select for protein-ligand interactions with moderate binding constants, only N1-adapter and medium phage can be used, because of the lower inhibitory effect of N1 at high concentrations. However, even with a very tight antibody-antigen binding system, as used here, high concentrations of the adapter are necessary, possibly re¯ecting a lower af®nity of the N1-Flu / medium-phage SIPcomplexes (Figure 5c ) to E. coli than of the N1-N2-Flu/ short-phage SIP-complex (Figure 5b ). This inhibitory effect thus seems to limit the achievable infection ef®ciency (cf N1-Bla-N2-CT over N1-N2Bla-CT in Table 1 ). The optimum curve using N1-N2-Flu (Figure 7 ) must be interpreted as being composed of the antigen-antibody binding curve (upwards slope) and an inhibition curve (downwards slope) (cf Figure 4) . The upward (binding) slope has a mid-point at approximately 10 À8 M, despite the fact that the anti-Flu scFv binds the antigen with a K D of 3 Â 10 À10 M (Vaughan et al., 1996) . This suggests, if equilibrium conditions apply, that single antigen-antibody binding events on the phage may not be suf®cient for high infectivity, but that several antibody-antigen pairs have to form on one phage. This multivalent docking of the phage to the pilus may also explain why the inhibition of infection by free¯uorescein requires a concentration as high as 10 À7 M (Figure 8 ). Thus, SIP will strongly favour antibody-displaying phages with high binding constants, when low concentrations of the adapter N1-N2-Ag are used. The examination of this concentration dependence was made possible by the puri®cation of the gIIIp domains and the adapter molecules and allowed us now to adjust the selection pressure in a rational way by changing adapter concentration. A biophysical understanding, however, will also require a more detailed knowledge of the mechanism and kinetics of the infection process.
In previously reported experiments, the cognate partners were genetically fused (Duenas & Borrebaeck, 1994; Gramatikoff et al., 1994; Krebber et al., 1995) . We have now shown that SIP can also be used with chemically coupled partners, thus expanding the range of possible interaction systems to organic molecules, sugars, eukaryotic proteins containing post-translational modi®cations or even proteins composed of D-amino acids (Schumacher et al., 1996) .
SIP experiments conducted without¯uorescein present in the adapter molecule, using scFv-fusion phage and only N1 and N1-N2, showed only one to ten infection events from an input of 10 10 phage particles, whereas for cognate antibody-antigen pairs under the most favourable conditions 10 4 to 10 5 (using anti-Flu short phage and N1-N2-Flu) and even 10 6 infection events (using anti-Flu medium phage and N1-Flu) could be detected. This low background infectivity rate shows that SIP is an extremely effective and highly speci®c method to select for cognate interaction events. When compared to phage display, a much lower background is observed, and in this one-step procedure the time consuming and generally inef®cient physical separation of cognate and non-speci®cally binding phages is obviated. SIP thus appears to be a very powerful method to select for ligand-binding proteins. In addition, the SIP strategy can possibly be extended to eukaryotic systems, where it might be used to design a vector for gene therapy, in which a virus is only infective in the presence of an exogenously added adapter protein.
Materials and Methods
Bacterial strains JM83 (ara, Á(lac-proAB), rpsL (strA), thi, f80, lacZÁM15) and endA1, gyrA96, hsdR17, supE44, relA1, lac [F`proAB lacI Q ZÁM15 Tn10 (Tet r )]) were conjugated to construct JM83-F . This was achieved by mixing exponentially growing cultures of the two strains for one hour at 37 C and subsequently plating these on 2xYT agar containing 30 mg/ml str and 15 mg/ml tet (Miller, 1972) . JM83-F bacteria and the F À strain JM83 constitute an isogenic pair that could be used as recipients to test the in¯uence of the F-pilus on infectivity of the Bla-gIIIp fusion phages. Both bacterial strains were grown in 2YTG (2xYT, 0.5% (w/v) glucose,and as the recipient for the infection by SIP complexes, was grown in 2YTG supplemented with 15 mg/ml tet. All bacterial cells were grown to an A 550 of 0.75 to 0.9 when used as recipient for infection experiments.
Construction of phage vectors
The scFv-displaying phage was constructed from the cam R derivative of the fd phage fCKC as described previously (Krebber et al., 1995) . Replacing either the ®rst N-terminal domain of gIIIp in the medium or both N-terminal domains in the short phage by a scFv fragment cloned between the RcaI and EcoRI restriction sites led to the production of non-infective scFv-displaying phage (Figure 3e ). The anti-Flu scFv FITC-E2 was ampli®ed by PCR from pCANTAB-FITC-E2 (Vaughan et al., 1996) and cloned into the S®I sites of a scFv-gIII fusion (Figure 3e) .
The b-lactamase gIIIp-insertion and deletion fusions were constructed by replacing the S®I scFv-cassette in the medium and short phage (Figure 3e ) with the b-lactamase gene, PCR-ampli®ed from pUC19 ( Figure 3b ). The RcaI-S®I pelB signal sequence cassette was replaced by a fragment encoding the N-terminal domains of gIIIp, including their gIII signal sequence, PCR-ampli®ed from M13mp19 (Figure 3b ). In the case of N2Bla-CT, N2 was initially fused behind a ompA signal sequence and then inserted as RcaI-S®I cassette (Figure 3b) . The expression of all phage gIIIp-fusions was under the control of the natural gIII promoter.
Growth and testing of the phages
Phages conferring cam resistance were produced from single colonies of XL1-Blue grown in 2YTG containing 15 mg/ml tet and 25 mg/ml cam ON at 37 C. All cultures of Bla-gIIIp fusion phages also contained 50 mg/ml amp. To test for the ability of the phages to produce plaques, culture supernatants were passed through an 0.22 mm ®l-ter and streaked on 2YTG agar containing 15 mg/ml tet. The plates were dried, and 5 ml top-agar containing 500 ml XL1-Blue cells were poured on the streaked plates.
The scFv-displaying phages were tested for binding to their antigen by standard ELISA (Krebber et al., 1995) , using FITC chemically coupled to lysine of human transferrin (Fluka). In order to check speci®city of binding, inhibition ELISAs were performed using soluble¯uor-escein as competitor (data not shown). The number of phage particles was estimated by spectrophotometry (Smith & Scott, 1993) .
Production of gIIIp domains and coupling to antigen
For the production of N1, N2 and N1-N2 proteins (Figure 3d ), corresponding fragments were PCR-ampli®ed from M13mp19 using Vent-polymerase (New England Biolabs) with primers which delete the signal sequence and introduce an N-terminal methionine and a C-terminal Ser-Gly-Cys-Pro-His 6 tag. Fragments were cloned into the vector pTFT74 (Freund et al., 1993) under the control of the T7 promoter. The N1, N2, and N1-N2 genes (without the signal sequence) were expressed in BL21(DE3), where N1 required the presence of pLysS (Studier & Moffat, 1986) , and obtained as cytoplasmic inclusion bodies. Puri®cation was carried out using the coupled IMAC-AIEX protocol, in the presence of 8 M urea (Plu È ckthun et al., 1996) . The protein was refolded by dialysis against 0.2 M Tris-HCl (pH 8.5), 0.4 M arginine, 0.2 M guanidinium-hydrochloride, 0.1 M (NH 4 ) 2 SO 4 , 2 mM EDTA, using a redox shuf¯e containing 1 mM oxidized glutathione and 0.2 mM reduced glutathione (Freund et al., 1993) . Micro sequencing and mass spectroscopy revealed that the methionine of the engineered start codon was cleaved, releasing the expected sequence NH 2 -AETVE for N1 and N1-N2 and giving the appropriate molecular mass. To remove the covalently linked glutathione, introduced by the refolding procedure, the N1 and N1-N2 proteins were mildly reduced using 5 mM dithiothreitol in 25 mM Tris-HCl (pH 8.5) at 4 C ON. The dithiothreitol was removed by gel ®ltration on a Sephadex G-25 (Pharmacia) column in 25 mM Na-phosphate (pH 6.8). Protein concentrations were calculated from A 280 (Gill & von Hippel, 1989) . Since the scFlu antibody was selected with FITC coupled to lysine (Vaughan et al., 1996) , but the directional coupling had to be to cysteine, we coupled 5-((5-aminopentyl)thioureidyl)¯uorescein (FluCad) (Molecular Probes Inc.) to the heterobifunctional crosslinker N-succinimidyl-6-maleimidocaproate (Fluka) via its primary amine (Figure 9 ). The reaction was carried out in DMF for one hour at 30 C in the dark, at a ratio of FluCad to crosslinker of 3:2. Completion of the reaction was controlled by thin layer chromatography. This reaction mixture was reacted, with FluCad in a threefold molar excess, with the free sulphydryl group of N1 or N1-N2 proteins for one hour at 25 C and then at 4 C ON. The resulting adapter proteins ( Figure 9 ) were gel ®ltrated on a Sephadex G25 column in 50 mM Tris (pH 7.5). The N-terminal domains of gIIIp, which were labelled with¯uorescein, were separated from the unlabelled in the same buffer on a perfusion chromatography HQ column with a NaCl gradient (0 to 600 mM), using a BioCAD 60 system (Perseptive Biosystems). The success of the process was monitored by micro sequencing, SDS-PAGE, mass spectroscopy, and spectrophotometry, all of which together indicated that the adapter proteins, N1-Flu and N1-N2-Flu, were 99% pure.
Infection experiments
For quanti®cation of the infectivity of b-lactamasegIIIp fusions, phage culture supernatants were PEG precipitated (0.25 vol. 17% PEG6000, 3.3 M NaCl, 1 mM EDTA; 30 minutes, 4 C; 30 minutes, 4 C, 4500 g) and redissolved in TBS (25 mM Tris-HCl, 140 mM NaCl, 2.7 mM KCl, pH 7.4). Bla-gIIIp fusion phage were added to JM83 and JM83-F cells and these cultures were shaken for one hour at 37 C prior to plating on 2YTG agar containing 30 mg/ml str and 50 mg/ml amp, and 15 mg/ ml tet in the case of F cells. In order to titre the phage fCKC, amp was omitted from the medium. The in¯uence of Ca 2 on the different Bla-gIIIp fusion constructs was tested by mixing 1 ml of JM83 and JM83-F with 50 ml of 1 M CaCl 2 immediately before addition to the phage.
The inhibitory effect of N1, N2 and N1-N2 was measured by mixing 10 ml of 10 4 -fold diluted N1-N2-Bla-CT fusion phage with 10 ml of different concentrations of N1, N1-Flu, N2, N1-N2 or N1-N2-Flu. These mixtures were added to 80 ml of XL1-Blue cells, shaken for one hour at 37 C and subsequently grown on 2YTG agar containing 25 mg/ml cam, 50 mg/ml amp, 15 mg/ml tet ON at 37 C. For SIP experiments, 5 ml of scFv-displaying phage supernatants, concentrated 200 times by PEG precipitation, was incubated with 10 ml of different concentrations of the N1, N1-Flu, N1-N2 or N1-N2-Flu proteins. After ON incubation at 4 C, 85 ml of XL1-Blue cells was added and the mixture was incubated for one hour at C with shaking. Aliquots and dilutions were subsequently plated on 2YTG agar containing 25 mg/ml cam, 15 mg/ml tet. The inhibitory effect of¯uorescein on SIP experiments was measured by preincubating the phage with N1-N2-Flu and free¯uorescein ON. The dependence of SIP on Mg 2 and Ca 2 was investigated by growing XL1-Blue without any addition of Mg 2 , and subsequently adding 50 ml of 1 M MgCl 2 or CaCl 2 to 1 ml of cells immediately before use. The indicated concentrations of the proteins N1, N1-Flu, N2, N1-N2, N1-N2-Flu and¯uorescein always refer to their ®nal concentrations in the presence of bacteria.
